Quantum Biopharma Ltd. Files June 2025 6-K Report
Ticker: QNTM · Form: 6-K · Filed: Jun 26, 2025 · CIK: 1771885
| Field | Detail |
|---|---|
| Company | Quantum Biopharma Ltd. (QNTM) |
| Form Type | 6-K |
| Filed Date | Jun 26, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: reporting, corporate-update, foreign-issuer
TL;DR
Quantum Biopharma (fka FSD Pharma) filed a 6-K on 6/26/25, confirming 20-F annual reports from Toronto.
AI Summary
Quantum Biopharma Ltd. (formerly FSD Pharma Inc.) filed a Form 6-K on June 26, 2025. The company, incorporated in A6 with its principal executive office in Toronto, Canada, is reporting under the 1934 Act. This filing is for the month of June 2025 and indicates the company files annual reports under Form 20-F.
Why It Matters
This filing provides routine updates for investors and regulatory bodies regarding Quantum Biopharma's reporting status and corporate information.
Risk Assessment
Risk Level: low — This is a routine filing (6-K) that does not appear to contain significant new financial or operational information.
Key Numbers
- 20250626 — Filing Date (Date of the Form 6-K submission)
Key Players & Entities
- Quantum Biopharma Ltd. (company) — Registrant
- FSD Pharma Inc. (company) — Former company name
- 20250626 (date) — Filing date
- Toronto, Canada (location) — Principal executive office location
- 001-39152 (other) — SEC File Number
FAQ
What is the primary purpose of this Form 6-K filing?
This Form 6-K is a Report of Foreign Private Issuer filed pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, for the month of June 2025.
What was Quantum Biopharma Ltd.'s former company name?
Quantum Biopharma Ltd.'s former company name was FSD Pharma Inc., with a date of name change on March 27, 2019.
Where is Quantum Biopharma Ltd.'s principal executive office located?
The company's principal executive office is located at 55 University Ave., Suite 1003, Toronto, Ontario M5J2H7, Canada.
Does Quantum Biopharma Ltd. file annual reports under Form 20-F or Form 40-F?
The filing indicates that the registrant files annual reports under cover of Form 20-F.
What is the SIC code for Quantum Biopharma Ltd.?
The Standard Industrial Classification (SIC) code for Quantum Biopharma Ltd. is 2834, Pharmaceutical Preparations.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on June 26, 2025 regarding Quantum Biopharma Ltd. (QNTM).